肺心病缓解期的中药运用规律研究  被引量:8

Study On The Traditional Chinese Medicine Of Cor Pulmonale

在线阅读下载全文

作  者:柏正平[1] 胡学军[1] 谭光波[1] 王帅[2] 甘荣[3] 柏莹[4] 

机构地区:[1]湖南省中医药研究院附属医院,湖南长沙410006 [2]浙江省宁波市第二医院,浙江宁波315010 [3]湖南省怀化市中医院,湖南怀化418000 [4]湖南中医药大学,湖南长沙410007

出  处:《中华中医药学刊》2012年第6期1311-1312,共2页Chinese Archives of Traditional Chinese Medicine

基  金:湖南省卫生厅重点资助项目(2008005)

摘  要:目的:通过文献研究,探讨肺心病缓解期的中药运用规律;方法:检索国内近15年(1996-2010)现有中医及中西医结合期刊杂志肺心病缓解期研究的有关报道,对本病处方用药方法进行分析、总结,提炼整理出本病的中药运用规律;结果:在符合纳入标准的151首方剂中,涉及中药85味,运用频次最高的药物分别是补气药(频率22.6%)、止咳化痰药(频率为17.4%)、活血化瘀药(频率12.1%),其次为利水渗湿药、清热药、补血药、解表药、补阳药、理气药、收涩药等。结论:近代临床医师在肺心病缓解期的中药运用中,以补虚为主,泻实为次,注重益气温(补)阳、活血化瘀、化痰降浊三法的综合运用,注重调理和改善肺、脾、肾三脏功能。Objective: Analyzes the traditional Chinese medicine of cor pulmonale through the literature research. Method: Search clinical reports about cor pulmonale in TCM or Chinese and Western integration domestic literatures from 1996 to 2010, statistics the law of the traditional Chinese medicines of cor pulmonale. Result: There are 85 traditional Chinese medicines in the 151 Qualified TCM Prescriptions. The highest used frequencies of of the traditional Chinese medicines are qi invigorating drugs (22.6%), Antitussive and Phlegm drugs (17.4%), Blood - activating and Stasis -eliminating Drugs (12. 1% ), the next drugs are damp -draining diuretic, heat -clearing drugs, blood -tonifying drugs, exterior - releasing drugs, yang - tonifying drugs, qi - regulating drugs, astringent drugs. Conclusion : Tonifying and replenishing medicine is more import than reducing excessiveness medicine in traditional Chinese medicine to Cor Pulmonale. We should pay attention to the comprehensive application of invigorating qi and warming yang, activating blood and resolving stasis, resolving phlegm and lowering chaotic. Conditioning the lungs,the spleen and the kidney.

关 键 词:肺心病 缓解期 中药 运用规律 文献研究 

分 类 号:R541[医药卫生—心血管疾病]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象